Is Ozempic a Once a Week Shot? Dosage and Routine Guide

Last reviewed: June 23, 2026

Last updated: June 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in Ozempic and Wegovy, is indeed a once-weekly injectable medication that works by stimulating GLP-1 receptors throughout your body. The standard clinical protocol involves starting at a low dose and increasing it every four weeks until reaching your target maintenance dose. PlexusDx offers compounded semaglutide injections through licensed 503A pharmacies, at $189/mo month-to-month, or from $149/mo on the 6-month plan with no flat per-compound pricing increases as your therapy advances.

How Semaglutide Injection Works as a Weekly Medication

Semaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist designed for once-weekly subcutaneous injection. Unlike short-acting GLP-1 drugs that require daily dosing, semaglutide's molecular structure allows it to bind to albumin in your bloodstream, creating a depot effect that sustains therapeutic levels for seven days. This extended half-life means you inject only once per week, typically on the same day each week, making adherence simpler than daily oral medications.

The medication activates GLP-1 receptors in your brain's appetite centers, pancreas, and gastrointestinal tract simultaneously. This multi-organ action reduces hunger signals, slows stomach emptying, and improves insulin secretion when blood sugar rises. Clinical trials demonstrate that weekly semaglutide injection produces more consistent weight loss and metabolic improvements compared to shorter-acting alternatives because the steady weekly dosing prevents the fluctuations seen with daily medications.

Understanding the Standard Semaglutide Dose Escalation Schedule

The typical semaglutide injection protocol begins at 0.25 mg weekly for the first four weeks, then increases by 0.25 mg every four weeks until reaching a target dose, usually 1.0 mg or 2.4 mg weekly depending on your clinical goals. This gradual titration approach allows your body to adapt to the medication while minimizing gastrointestinal side effects like nausea. Most patients move through the dose ladder over 16 to 20 weeks before stabilizing at their maintenance dose. PlexusDx partners with licensed 503A compounding pharmacies to provide semaglutide at consistent monthly pricing regardless of which dose tier you're using, ensuring your monthly cost remains flat as your clinical needs evolve.

Your healthcare provider at PlexusDx may pause or slow your dose progression if you experience bothersome side effects, or may advance your dose more quickly if you're tolerating the medication well. The dose escalation is flexible and individualized—there's no one-size-fits-all timeline. Some patients reach their target dose in four months, while others take up to six months to titrate safely. Your provider monitors your response at each step, adjusting the schedule based on your specific tolerance and weight loss progress.

Injection Technique and Weekly Administration Routine

Semaglutide injection is self-administered using a pre-filled pen or syringe into the subcutaneous tissue of your abdomen, thigh, or upper arm once per week. Most patients choose a consistent day and time—for example, every Monday morning—to build a reliable routine. The injection takes less than 10 seconds and uses a very fine needle (similar to insulin pens), making it virtually painless for most people. You'll receive detailed instruction videos and written guidance from PlexusDx on proper injection technique, needle disposal, and medication storage at room temperature.

Rotating your injection sites among your abdomen, thighs, and upper arms helps prevent lipodystrophy (localized fat changes) and maintains consistent absorption. Unlike insulin, semaglutide doesn't require refrigeration once dispensed and remains stable at room temperature for up to 30 days. Many patients find the once-weekly schedule more convenient than daily pills or multiple daily injections, leading to better long-term adherence and sustained weight loss results over 12 months or longer.

Comparing Semaglutide Injection to Oral and Alternative Delivery Options

PlexusDx offers semaglutide in multiple formats to match your preference: compounded semaglutide injection (once-weekly, at $189/mo month-to-month, or from $149/mo on the 6-month plan), oral semaglutide tablets (daily dosing, at $289/mo month-to-month, or from $249/mo on the 6-month plan), and the GLP-Squared Injection combining semaglutide with tirzepatide (at $289/mo month-to-month, or from $249/mo on the 6-month plan) for patients seeking dual-peptide activation. Injectable semaglutide typically produces faster weight loss and more consistent metabolic control because it bypasses digestive absorption variability that affects oral formulations. Injection also allows for more precise dose titration in 0.25 mg increments, whereas oral tablets come in fixed doses.

If you prefer not to inject, PlexusDx compounded oral semaglutide provides a tablet-based alternative taken once daily, though it may require higher cumulative doses to achieve comparable results. Your PlexusDx provider will help you select the delivery method that fits your lifestyle, medical history, and response profile. The Precision Peptide Genetic Test can also describe the pathway-level variants involved, whether your GLP1R rs6923761 variant suggests strong responsiveness to semaglutide—helping guide your choice between semaglutide, tirzepatide, or dual-compound therapy.

What to Expect During Your First Weeks on Weekly Semaglutide

Most patients notice reduced appetite and early satiety within the first one to two weeks of starting semaglutide at 0.25 mg. Some experience mild nausea during the initial titration phase, which typically improves as your body adapts and which often resolves completely by week three or four. Weight loss usually becomes measurable by week four, with average losses of 1 to 2 pounds per week during the titration phase and accelerating further once you reach your target dose. Your PlexusDx provider will schedule follow-up check-ins at each dose increase to assess your tolerance and progress.

By month four, when most patients reach their target maintenance dose, you'll have established a clear weekly routine and likely experienced significant appetite suppression and early satiety signals. Many patients report that food cravings diminish substantially, making it easier to maintain a calorie deficit without severe hunger. Your PlexusDx team provides ongoing support through telehealth visits, educational resources about nutrition and movement, and dose adjustments if needed based on your individual response and goals.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

Is Ozempic really given once per week?

Yes, semaglutide (Ozempic and Wegovy) is a once-weekly injectable medication administered every seven days via subcutaneous injection. The long-acting formulation maintains therapeutic blood levels throughout the week, eliminating the need for daily dosing. PlexusDx offers compounded semaglutide injection through licensed 503A pharmacies, allowing you to inject once weekly on a schedule that fits your routine.

How long does it take to reach my full semaglutide dose?

Standard titration takes 16 to 20 weeks, increasing by 0.25 mg every four weeks starting from 0.25 mg in week one. Most patients stabilize at 1.0 mg or 2.4 mg weekly depending on their clinical goals and tolerance. Your PlexusDx provider may adjust this timeline based on how you respond, potentially slowing progression if side effects occur or advancing more quickly if you tolerate each dose well.

Will my PlexusDx semaglutide cost increase as my dose goes up?

No. PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) flat pricing across all dose tiers—your dose may need to go up, but your price won't. This flat-rate structure ensures you're never charged more as your therapy advances through the titration schedule, and there's no membership fee or insurance requirement.

What are the most common side effects during the first month?

Mild to moderate nausea is the most frequently reported early side effect, typically occurring in the first one to two weeks and often resolving by week three or four as your body adapts. Other common initial effects include constipation, reduced appetite (which is therapeutic), and occasional fatigue. Serious side effects are rare; your PlexusDx provider monitors you at each dose increase to ensure safety and manage any bothersome symptoms.

How does my genetic profile affect my semaglutide response?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ozempic Shot
• Lifemd Ozempic
• Eden Ozempic
• Ro Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.